LigaChem Biosciences Inc.
KOE: 141080.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yong Zu Kim
- Employees
- 163
- Headquarters
- Daejeon, South Korea
- IPO year
- 2013
- Market cap
- ₩6.8T
- Website
- https://ligachembio.com
Loading 141080…
Loading profile data…Frequently asked questions about 141080
What does LigaChem Biosciences Inc. (141080.KQ) do?
LigaChem Biosciences, Inc. engages in the development, manufacture of medicines, medical devices and medical supplies. It offers medical equipment and therapeutic products such as antibiotics, anti-coagulants, oncology, antibody-drug conjugate, and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, So...
Where does 141080.KQ trade?
LigaChem Biosciences Inc. (141080.KQ) trades on the KOSDAQ.
What sector is 141080.KQ in?
LigaChem Biosciences Inc. (141080.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of LigaChem Biosciences Inc.?
Yong Zu Kim is the chief executive officer of LigaChem Biosciences Inc. (141080.KQ).
Where is LigaChem Biosciences Inc. headquartered?
LigaChem Biosciences Inc. is headquartered in South Korea.
Does 141080.KQ pay a dividend?
LigaChem Biosciences Inc. (141080.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 141080.KQ go public?
LigaChem Biosciences Inc. (141080.KQ) completed its initial public offering in 2013.